Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
US Equity Holdings
San Francisco, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
US Equity Holdings is a holding company with investments in multiple biotech and pharmaceutical ventures. Its portfolio companies develop small-molecule antivirals (Prosetta Biosciences), drug delivery devices (Credence MedSystems), oral thin films (Cure Pharmaceutical), regenerative biologics and epigenetic biomarkers (Aelan Cell Technologies), and mTOR modulators for autoimmune diseases (Mount Tam Biotechnologies), including a pre-IND program for lupus.
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- Small MoleculeDrug Delivery DevicesOral Thin FilmsRegenerative BiologicsmTOR Modulators
- Industry
- Investors
02
Partnerships
Beyond the preview
Go deeper on US Equity Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on US Equity Holdings.